Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$21,466 Mln
Revenue (TTM)
$5,828 Mln
Net Profit (TTM)
$708 Mln
ROE
0.1 %
ROCE
6.6 %
P/E Ratio
30.5
P/B Ratio
3
Industry P/E
--
EV/EBITDA
15.5
Div. Yield
1.1 %
Debt to Equity
0.3
Book Value
$72.9
EPS
$7.2
Face value
--
Shares outstanding
98,075,025
CFO
$5,617.17 Mln
EBITDA
$5,573.64 Mln
Net Profit
$2,484.97 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
STERIS plc (Ireland) (STE)
| -13.7 | -13.3 | -13.7 | -3.1 | 4.6 | 2.5 | 11.7 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
STERIS plc (Ireland) (STE)
| 23.3 | 19.0 | -24.1 | 28.4 | 24.4 | 42.6 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility... assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio. Read more
President, CEO & Director
Mr. Daniel A. Carestio
President, CEO & Director
Mr. Daniel A. Carestio
Headquarters
Mentor, OH
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of STERIS plc (Ireland) (STE) is $218.71 (NYSE) as of 02-Apr-2026 19:00 EDT. STERIS plc (Ireland) (STE) has given a return of 4.57% in the last 3 years.
The P/E ratio of STERIS plc (Ireland) (STE) is 30.50 times as on 02-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
36.42
|
3.39
|
|
2024
|
58.76
|
3.53
|
|
2023
|
177.94
|
3.13
|
|
2022
|
99.92
|
3.73
|
|
2021
|
41.24
|
4.21
|
The 52-week high and low of STERIS plc (Ireland) (STE) are Rs 269.44 and Rs 204.90 as of 04-Apr-2026.
STERIS plc (Ireland) (STE) has a market capitalisation of $ 21,466 Mln as on 02-Apr-2026. As per SEBI classification, it is a company.
Before investing in STERIS plc (Ireland) (STE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-1.23
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.